Fundraising Fox

Luminary Therapeutics

Minneapolis, US · Founded 2019 · Delaware corporation · 1 known investors

luminarytx.com
BiotechHealthtechMedical Devices

Founders & leadership

JL
Jeff LiterExecutive Officer, Director, Promoter
JH
James HaymakerDirector, Promoter
DL
David LargaespadaExecutive Officer, Director, Promoter
JR
Jeff RossDirector
JW
John WellsDirector
TL
Tracey LodieDirector
MC
Mark ChanceDirector

Investors · 1

Reported raises · per SEC filings

Form D private placements
$1.4MraisedNov 2025 · 6 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Branden MoriarityDirector
  • Mark ChanceDirector
  • Tracey LodieDirector
  • James HaymakerDirector, Promoter
  • John WellsDirector
  • Jeff RossDirector
  • Jeff LiterExecutive Officer, Director, Promoter
Offering amount
$12.4M
Amount sold
$1.4M
First sale
Oct 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$5.2MraisedJan 2025 · 49 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Tracey LodieDirector
  • Jeff LiterExecutive Officer, Director, Promoter
  • Jeff RossDirector
  • James HaymakerDirector, Promoter
  • Mark ChanceDirector
  • John WellsDirector
Offering amount
$5.5M
Amount sold
$5.2M
First sale
Sep 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$5.2MraisedJan 2025 · 48 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jeff RossDirector
  • Jeff LiterExecutive Officer, Director, Promoter
  • John WellsDirector
  • James HaymakerDirector, Promoter
  • Tracey LodieDirector
  • Mark ChanceDirector
Offering amount
$5.9M
Amount sold
$5.2M
First sale
Nov 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$375KraisedNov 2021 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jim HaymakerDirector
  • David LargaespadaExecutive Officer, Director, Promoter
  • Jeff LiterExecutive Officer, Director, Promoter
  • John WellsDirector
  • Tracey LodieDirector
  • George CoxDirector
Offering amount
$1.5M
Amount sold
$375K
First sale
Oct 2021
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$825KraisedFeb 2021 · 11 investors · Biotechnology
Officers, directors & promoters on the filing
  • Jim HaymakerDirector
  • Tracey LodieDirector
  • George CoxDirector
  • John WellsDirector
  • Jeff LiterExecutive Officer, Director, Promoter
  • David LargaespadaExecutive Officer, Director, Promoter
Offering amount
$1M
Amount sold
$825K
First sale
Jan 2021
Incorporated
Corporation, Delaware, 2019
Federal exemptions
04
Full filing on SEC EDGAR ↗
$1.5MraisedNov 2019 · 11 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • David LargaespadaExecutive Officer, Director, Promoter
  • Jeff LiterExecutive Officer, Director, Promoter
Offering amount
$1.5M
Amount sold
$1.5M
First sale
Oct 2019
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.